New hope for slowing rare adrenal tumors
NCT ID NCT03946527
Summary
This study is testing whether monthly injections of a drug called lanreotide can help control advanced or metastatic pheochromocytoma and paraganglioma—rare tumors that form in nerve tissue. It will enroll about 10 adults to see if the treatment safely slows tumor growth compared to how fast their tumors were growing before the study. Researchers will also track survival, tumor response, and changes in hormone levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.